Biography
Professor YU Yinghua is a Distinguished Professor of Jiangsu Province. She received her PhD from the University of Wollongong, Australia. She worked as a Research Fellow and Senior Scientist at the University of Wollongong and Schizophrenia Research Institute in Australia from 2009-2016. Since 2016, as a professor, she has joined Xuzhou Medical University, Key Laboratory of Immunity and Metabolism of Jiangsu Province. Her research interests are the gut-brain axis as well as the pathogenesis and intervention of chronic metabolic diseases and associated neurodegenerative diseases. As chief investigator, she has received many research projects from Australia and China, including the National Health and Medical Research Council of Australia (NHMRC), the Diabetes Australia Research Trust, the University of Wollongong Research Fund, the National Natural Science Project, and the Major Natural Science Research Project of Jiangsu Provincial Universities. She has published more than 90 SCI papers. As the first author or corresponding author, she has published in the Journal of Clinical Investigation (IF 19.465), Microbiome (IF 16.837), Brain behaviour and immunity (IF 15.1), Obesity review (IF 9.213), and other internationally renowned journals. She has supervised 15 doctoral students and 21 master's students. More information about Prof. Dr. Wang’s publication record can be accessed via the link below：
Yinghua Yu | Research outputs | University of Wollongong
Yinghua Yu (0000-0003-2508-7512) - ORCID
Academic Awards
Prof. Yu received many prestigious academic awards in the field of Neurodegenerative disease and metabolic syndrome. For instance, the Performance Award from the Diabetes Australia Research Trust. Training Fellowship of National Health and Medical Research Council of Australia.
Publications
Representative publications:
1. Ge Xing, Zheng Mingxuan, Hu Minmin, Fang Xiaoli, Geng Deqin, Liu Sa, Wang Li, Zhang Jun, Guan Li, Zheng Peng, Xie Yuyi, Pan Wei, Zhou Menglu, Zhou Limian, Tang Renxian, Zheng Kuiyang*, Yu Yinghua*, Huang Xu-Feng*.(2023). Butyrate ameliorates quinolinic acid-induced cognitive decline in obesity models. Journal of Clinical Investigation, 133(4).
2. Pan Wei, Zhao Jinxiu, Wu Jiacheng, Xu Daxiang, Meng Xianran, Jiang Pengfei, Shi Hongli, Ge Xing, Yang Xiaoying, Hu Minmin, Zhang Peng, Tang Renxian, Nagaratnam Nathan, Zheng Kuiyang*, Huang Xu-Feng*, Yu Yinghua*. (2023). Dimethyl itaconate ameliorates cognitive impairment induced by a high-fat diet via the gut-brain axis in mice. Microbiome, 11(1): 30.
3. Xing Ge, Minmin Hu, Menglu Zhou, Xiaoli Fang, Xi Chen; Deqin Geng, Li Wang, Xiaoying Yang, Huimei An, Meng Zhang, Danhong Lin, Mingxuan Zheng, Xiaoying Cui, Qing Wang, Yuqing Wu*, Kuiyang Zheng*, Xu-Feng Huang*, Yu Yinghua*. Overexpression of forebrain PTP1B leads to synaptic and cognitive impairments in obesity, Brain Behavior and Immunity, 2024, 117: 456-470.
4. Xing Ge, Minmin Hu, Menglu Zhou, Xiaoli Fang, Xi Chen; Deqin Geng, Li Wang, Xiaoying Yang, Huimei An, Meng Zhang, Danhong Lin, Mingxuan Zheng, Xiaoying Cui, Qing Wang, Yuqing Wu*, Kuiyang Zheng*, Xu-Feng Huang*, Yu Yinghua*. Overexpression of forebrain PTP1B leads to synaptic and cognitive impairments in obesity, Brain Behavior and Immunity, 2024, 117: 456-470.
5. Hongli Shi, Xing Ge, Xi Ma, Mingxuan Zheng, Xiaoying Cui, Wei Pan, Peng Zheng, Xiaoying Yang, Peng Zhang, Minmin Hu, Tao Hu, Renxian Tang, Kuiyang Zheng*, Xu-Feng Huang*, Yinghua Yu*. A fiber-deprived diet causes cognitive impairment and hippocampal microglia-mediated synaptic loss through the gut microbiota and metabolites. Microbiome. 2021, 11;9(1):223.
6. Hongli Shi, Yinghua Yu*, Danhong Lin, Peng Zheng, Peng Zhang, Minmin Hu, Qiao Wang, Wei Pan, Xiaoying Yang, Tao Hu1, Qianqian Li, Renxian Tang, Feng Zhou1, Kuiyang Zheng*, Xu-Feng Huang* β-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice. Microbiome. 2020, 8, Article number: 143.
